Based on these, we speculate that UCHL3 activates the AKT/CCND1 pathway via ENO1, and subsequent rescue experiments confirm ENO1’s pivotal role in UCHL3-mediated AKT/CCND1 signaling regulation for GC progression. Here, AKT1 is linked to gastric cancer.